You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complete Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial (Naxitamab)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Sep 18, 2023

t Pathologic Complete Response Observed in HER2 Positive Breast

Completed
  • HER2+ Breast Cancer
  • Rawalpindi, Punjab, Pakistan
    Rawalpindi Medical University
Jun 26, 2023

Axillary Lymph Node Dissection, Pathological Complete Response, Neoadjuvant Systemic Therapy Trial in Nanjing (Stained region

Recruiting
  • Axillary Lymph Node Dissection
  • +4 more
  • Stained region Lymph Node Biopsy (SrLNB)
  • Regional lymph node radiotherapy (RNI) including the axilla
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Jul 10, 2023

MRI Criterion After Neoadjuvant Therapy in Locally Advanced

Completed
  • Rectal Neoplasms
    • Nîmes, Gard, France
      Chu de Nîmes
    Sep 8, 2022

    Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response

    Recruiting
    • Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
    • Vacuum-assisted biopsy
    • Saint-Petersburg, Russian Federation
      Petr Krivorotko
    Jun 14, 2022

    Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

    Not yet recruiting
    • Inflammatory Breast Cancer
    • Breast conserving surgery
    • Radical modified mastectomy
    • (no location specified)
    Nov 14, 2023

    Breast Cancer Trial (Omission of radiotherapy)

    Not yet recruiting
    • Breast Cancer
    • Omission of radiotherapy
    • (no location specified)
    Jun 8, 2022

    Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Guangzhou (drug, radiation, procedure, other)

    Recruiting
    • Rectal Cancer
    • +3 more
    • Capecitabine, Oxaliplatin
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 19, 2022

    Early Predict Pathological Complete Response to Neoadjuvant

    Recruiting
    • Breast Cancer
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Aug 8, 2022

      Locally Advanced Basal Cell Carcinoma Trial in Brescia (Sonidegib)

      Recruiting
      • Locally Advanced Basal Cell Carcinoma
      • Brescia, Italy
        Asst Degli Spedali Civili Di Brescia
      Aug 3, 2022

      Predictive Factor of Pathologic Complete Response After

      Completed
      • Rectum Cancer
        • Bangkok, Bankok, Thailand
          Chairat Supsamutchai
        May 15, 2022

        Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to

        Active, not recruiting
        • Esophageal Cancer
        • follow up
        • Guangzhou, Guangdong, China
          Jianhua Fu
        Sep 24, 2023

        The ImmunoXXL Study

        Recruiting
        • Hepatocellular Carcinoma
        • Liver Transplantation
        • Milano, MI, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori
        May 25, 2023

        Metastatic Colorectal Cancer Trial (Niraparib)

        Not yet recruiting
        • Metastatic Colorectal Cancer
        • (no location specified)
        Jun 7, 2022

        Radiation OmisSion in PAtients With CLinically Node Negative

        Not yet recruiting
        • Breast Cancer
          • (no location specified)
          May 10, 2023

          Rectal Cancer, Feasibility, Toxicity Trial (Maastro applicator)

          Not yet recruiting
          • Rectal Cancer
          • +7 more
          • Maastro applicator
          • (no location specified)
          Oct 13, 2023

          PTCL Patients Who Achieved Complete Response From Frontline Treatment Trial (Selinexor)

          Not yet recruiting
          • PTCL Patients Who Achieved Complete Response From Frontline Treatment
          • (no location specified)
          Apr 18, 2023

          Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

          Not yet recruiting
          • Triple Negative Breast Neoplasms
          • Xiaopi granules
          • +2 more
          • (no location specified)
          Nov 22, 2023

          Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

          Recruiting
          • Head and Neck Squamous Cell Carcinoma
          • dose-reduced radiotherapy
          • Zhuhai, Guangdong, China
            Fifth Affiliated Hospital of Sun Yat-sen University
          May 3, 2023

          Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

          Recruiting
          • Locally Advanced Rectal Carcinoma
          • +2 more
          • Gainesville, Florida
          • +1 more
          Jan 4, 2023

          Rectal Adenocarcinoma Trial in Tampa (Capecitabine, Radiation Therapy, FOLFOX regimen)

          Recruiting
          • Rectal Adenocarcinoma
          • Tampa, Florida
            Moffitt Cancer Center
          Jan 24, 2023

          Melanoma Trial in Rotterdam (Nivolumab)

          Recruiting
          • Melanoma
          • Rotterdam, Pending, Netherlands
            Erasmus MC
          Oct 30, 2023

          HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

          Active, not recruiting
          • HER2-positive Breast Cancer
          • PIK3CA analysis
          • Rome, RM, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Feb 20, 2023

          Basal Cell Carcinoma, Radiotherapy; Complications Trial (radiation, other, drug)

          Not yet recruiting
          • Basal Cell Carcinoma
          • Radiotherapy; Complications
          • Radiotherapy
          • +2 more
          • (no location specified)
          Sep 30, 2022

          Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in

          Active, not recruiting
          • Anatomic Stage IIIB Breast Cancer AJCC v8
          • +4 more
          • Pembrolizumab
          • Houston, Texas
            M D Anderson Cancer Center
          Sep 30, 2022